| |
Latest 10 SEC filings (by transaction date) for MNOV within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Jan 11/24 | Jan 9/24 | OBrien Geoffrey | Direct Ownership | Employee Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 84,000 | |
Jan 11/24 | Jan 9/24 | Matsuda Kazuko | Direct Ownership | Employee Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 157,500 | |
Jan 11/24 | Jan 9/24 | Iwaki Yuichi | Direct Ownership | Employee Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 210,000 | |
Aug 8/23 | Aug 4/23 | Lemerond Nicole | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 18,333 | |
Jun 15/23 | Jun 13/23 | Nagao Hideki | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 20,000 | |
Jun 15/23 | Jun 13/23 | Beaver Carolyn | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 20,000 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for MNOV within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Jan 11/24 | Jan 9/24 | OBrien Geoffrey | Direct Ownership | Employee Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 84,000 | |
Jan 11/24 | Jan 9/24 | Matsuda Kazuko | Direct Ownership | Employee Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 157,500 | |
Jan 11/24 | Jan 9/24 | Iwaki Yuichi | Direct Ownership | Employee Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 210,000 | |
Aug 8/23 | Aug 4/23 | Lemerond Nicole | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 18,333 | |
Jun 15/23 | Jun 13/23 | Nagao Hideki | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 20,000 | |
Jun 15/23 | Jun 13/23 | Beaver Carolyn | Direct Ownership | Stock Option (Right to Buy) | A - Grant, award or other under Rule 16b-3(d) | 20,000 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Neurocrine Biosciences (OQ:NBIX) |
Regeneron Pharmaceuticals (OQ:REGN) |
Madrigal Pharmaceuticals (OQ:MDGL) |